Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Work at G. Pohl-Boskamp GmbH & Co. KG? so we know who speaks for it.
Their record over time
G. Pohl-Boskamp GmbH & Co. KG filed 2 positions between 7 Mar 2025 and 26 Jan 2026, across 2 of the 326 legislative files tracked here, attaching a full position paper 2 times.
G. Pohl-Boskamp GmbH & Co. KG warmly welcomes the European Commission’s initiative to adapt the EU public procurement directives (2014/23/EU, 2014/24/EU and 2014/25/EU) in order to take account, in particular, of the need for action from the mid-caps of the pharmaceutical industry, which still account for a significant share of generic pharmaceutical production in the EU.
Filed in German · English published by the European Commission
The objective of adapting Directives 2014/23/EU, 2014/24/EU and 2014/25/EU should be to allow contracting authorities to design tender conditions in a way that preserves the diversity of suppliers and avoids shortages of supply (in particular pharmaceutical products).
Filed in German · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Everything on this page comes from G. Pohl-Boskamp GmbH & Co. KG’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.